AKTX

Akari Therapeutics, Plc

HealthcareBiotechnologyGBUSDPeers →Country macro →

$11.96

LiveJun 23, 2026

AI Brief

Market cap

$13.68M

52w range

3.02 – 49.60

P / E

—

EPS

—

Volume

23.98K

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Akari Therapeutics, Plc’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for AKTX.

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $1,200.00 (+9937.64%)

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+6.46%	-0.54%	-34.56%	+106.12%	+21.87%	+3.42%	-74.23%	-90.72%	-99.12%	-99.89%	-99.91%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 23, 03:51 PM

Last trade

$11.96

21 sh

Bid

$11.49

2 sh

Ask

$12.50

8 sh

Spread

$1.010

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.39%
Technology
+1.16%
Utilities
+0.92%
Communication Services
+0.72%
Energy
+0.43%
Consumer Defensive
+0.34%
Financial Services
+0.22%
Basic Materials
+0.16%
Consumer Cyclical
+0.12%
Healthcare
-0.34%
Industrials
-0.52%

Top industries (issuer's industry highlighted)

Biotechnology
+2.86%
Software - Services
+5.98%
Electronic Gaming & Multimedia
+4.44%
Investment - Banking & Investment Services
-3.81%
Medical - Equipment & Services
+3.76%
Travel Services
+3.38%
Communication Equipment
+2.94%
Independent Power Producers
+2.74%
Manufacturing - Metal Fabrication
+2.71%
Broadcasting
+2.54%
Computer Hardware
+2.32%
Financial - Mortgages
+2.13%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for AKTX.

Peers

No peer list available for AKTX.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin